Skip to Main Content

Paper Details

Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapib.
Am Heart J
16
2020
Author NameAffiliation
Jean-Claude TardifMontreal Heart Institute, Universite de Montreal
Vincent MooserCentre Hospitalier Universitaire Vaudois
Vincent MooserCentre Hospitalier Universitaire Vaudois
  • 1 - 3

Datasets

Release 1.2